Focusing On Six Important Therapeutic Areas
We are actively developing treatments for our patients in six important therapeutic areas of healthcare. Our solutions address some of the world’s most serious conditions and diseases.
More than just products and individual treatments, Janssen wants to provide solutions in disease management, including collaboration with private and public parties to monitor and manage health.
Cardiovascular and metabolic diseases
Cardiovascular and metabolic diseases are a major threat to life for adults, accounting for millions of deaths worldwide each year. Heart disease is the number one killer in both men and women. Diabetes is the fourth leading cause of death in most developed countries. We are building a comprehensive approach to diabetes care as well as cardiovascular disease.
We have a strong history of delivering biological medicines for immunological diseases and we continue to build a pipeline of exciting, new biotechnological products, while expanding into small-molecule oral medications and broadening our disease focus in autoimmune, inflammatory and pulmonary diseases. Through our ongoing efforts in discovery, biomarkers, clinical research and external innovation, we are poised for continued leadership and growth, bringing transformational medicines to patients and healthcare providers around the world.
Infectious Diseases and Vaccines
Our goal is to change people’s lives and to improve public health by fighting infectious diseases worldwide. Demand for antibiotics remains high due to escalating resistance and the increased risk of serious infections in patients with weakened immune systems. We are developing innovative solutions for key unmet needs such as HIV, tuberculosis and hepatitis C.
Neuropsychiatric illnesses are the most significant disease burden in high income countries and are expected to grow substantially in other regions of the world as the standard of living increases. Our mission is to transform individual lives. We are also focused on developing medicines to relieve severe chronic pain and we strive to raise the global standard of pain relief. Our core strength in research and development builds on our expertise in ADHD, Bipolar Disorder, Dementia, Epilepsy, Schizophrenia and Migraine and Pain Management.
Cancer claims over seven million lives every year and the number continues to rise. Deaths are estimated to reach 12 million by 2030. We aim to transform cancer to a preventable, chronic or curable disease by delivering extraordinary diagnostic and therapeutic solutions that prolong and improve patients’ lives. We are committed to delivering targeted therapies to fight the devastation of cancer.
Other Therapeutic Areas
Janssen is committed to bringing highly effective medicines onto the market. Rather than just products and individual treatments, Janssen wants to provide solutions in disease management, including collaboration with private and public parties to monitor, prevent and manage health.